Publicaciones en las que colabora con María Dolores Tabernero Redondo (10)

2017

  1. Relevance of Simpson's grading system for resections in WHO grade I meningiomas

    Neurocirugia, Vol. 28, Núm. 4, pp. 176-182

2016

  1. Tumor infiltrating immune cells in gliomas and meningiomas

    Brain, Behavior, and Immunity, Vol. 53, pp. 1-15

2015

  1. Genetic/molecular alterations of meningiomas and the signaling pathways targeted

    Oncotarget, Vol. 6, Núm. 13, pp. 10671-10688

  2. The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 3, pp. 319-332

2014

  1. Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype

    Neuro-Oncology, Vol. 16, Núm. 5, pp. 735-747

2013

  1. Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas

    PLoS ONE, Vol. 8, Núm. 10

  2. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas

    BMC Medical Genetics, Vol. 14, Núm. 1

2005

  1. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: Correlation with clinical, histopathologic, and prognostic features

    American Journal of Clinical Pathology, Vol. 123, Núm. 5, pp. 744-751

2004

  1. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): Is there a relationship between histopathologically benign and atypical/anaplastic lesions?

    Journal of Molecular Diagnostics, Vol. 6, Núm. 4, pp. 316-325

2001

  1. Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients

    Cancer, Vol. 92, Núm. 2, pp. 377-385